KOFAX IMAGE PRODUCTS INC
10-Q, 1999-05-14
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: FRANCHISE MORTGAGE ACCEPTANCE CO, 10-Q, 1999-05-14
Next: TIER TECHNOLOGIES INC, 8-K, 1999-05-14



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 10-Q


[X]   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES 
      EXCHANGE ACT OF 1934

      FOR QUARTERLY PERIOD ENDED MARCH 31, 1999

[ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
      EXCHANGE ACT OF 1934 

      FOR THE TRANSITION PERIOD FROM _____________ TO ___________


                        Commission File Number 000-23119


                           KOFAX IMAGE PRODUCTS, INC.
- -------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

           DELAWARE                                           33-0114967
- -------------------------------                           -------------------
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                           Identification No.)

16245 Laguna Canyon Rd, Irvine, California                       92618
- ------------------------------------------                -------------------
 (Address of principal executive offices)                      (Zip Code)

                                 (949) 727-1733
- -------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                    3 Jenner Street, Irvine, California 92618
- -------------------------------------------------------------------------------
                     (Former name, former address and former
                   fiscal year, if changed since last report)


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X  No
                                             ---   ---

         Indicate the number of shares outstanding of each of the issuer's
classes of common stock as of the latest practical date.

          Class                                  Outstanding at April 30, 1999
- -----------------------------                    -----------------------------
Common Stock, $.001 par value                            5,303,701 shares



<PAGE>   2

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY

                                      INDEX

<TABLE>
<CAPTION>

 ITEM                                                                                 PAGE  
NUMBER                                                                               NUMBER 
- ------                                                                               ------ 
<S>             <S>                                                                  <C>    
PART I.         FINANCIAL INFORMATION                                                       
                                                                                            
ITEM 1.         Condensed Consolidated Financial Statements                                 
                                                                                            
                Condensed Consolidated Balance Sheets - March 31, 1999                      
                    (unaudited) and June 30, 1998................................       3   
                                                                                            
                Condensed Consolidated Statements of Operations (unaudited) -               
                    Three Months Ended March 31, 1999 and 1998                              
                    and Nine Months Ended March 31, 1999 and 1998................       4   
                                                                                            
                Condensed Consolidated Statements of Cash Flows (unaudited) -               
                    Nine Months Ended March 31, 1999 and 1998....................       5   
                                                                                            
                Notes to Condensed Consolidated Financial                                   
                    Statements (unaudited).......................................       6   
                                                                                            
ITEM 2.         Management's Discussion and Analysis of Financial                           
                    Condition and Results of Operations..........................       8   
                                                                                            
                                                                                            
PART II.        OTHER INFORMATION                                                           
                                                                                            
ITEM 3.         Legal Proceedings................................................      15   
                                                                                            
ITEM 6.         Exhibits and Reports on Form 8-K.................................      15   
                                                                                            
                Signatures.......................................................      16   

</TABLE>


                                       2


<PAGE>   3

                         PART I - FINANCIAL INFORMATION

ITEM 1.  CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY
                      Condensed Consolidated Balance Sheets
                        (in thousands, except share data)

<TABLE>
<CAPTION>
                                                                                  March 31,      June 30,
                                                                                    1999           1998
                                                                                  ---------      --------
                                                                                 (unaudited)
                                ASSETS
<S>                                                                               <C>           <C>     
Current assets
       Cash and cash equivalents                                                  $ 19,851      $ 16,522
       Short-term investments                                                        5,467         4,343
       Accounts receivable, net                                                      5,106         5,261
       Inventory (Note 2)                                                            1,769         1,565
       Prepaid expenses and other current assets                                     1,519           948
                                                                                  --------      --------
Total current assets                                                                33,712        28,639
Property and equipment, net                                                          1,485         1,740
Deferred income taxes                                                                1,343         1,343
Other assets                                                                           104           393
                                                                                  --------      --------
Total assets                                                                      $ 36,644      $ 32,115
                                                                                  ========      ========

                 LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities
       Accounts payable                                                           $  1,254      $  1,207
       Accrued liabilities:
           Compensation                                                              1,623         1,237
           Deferred revenue                                                            880           588
           Other                                                                     2,246         1,458
                                                                                  --------      --------
Total current liabilities                                                            6,003         4,490

Stockholders' equity
       Common stock, $.001 par value, 40,000,000 shares authorized; 
         5,332,876 and 5,307,416 shares issued and outstanding at 
         March 31, 1999 and June 30, 1998                                           17,156        17,125
       Retained earnings                                                            14,040        11,136
       Treasury stock, 87,865 and 100,000 shares at cost at 
         March 31, 1999 and June 30, 1998                                             (555)         (636)
                                                                                  --------      --------
Total stockholders' equity                                                          30,641        27,625
                                                                                  --------      --------
Total liabilities and stockholders' equity                                        $ 36,644      $ 32,115
                                                                                  ========      ========
</TABLE>



The accompanying notes are an integral part of these condensed consolidated
financial statements.



                                       3

<PAGE>   4

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY
                 Condensed Consolidated Statement of Operations
                      (in thousands, except per share data)

<TABLE>
<CAPTION>
                                             Three Months Ended       Nine Months Ended
                                                  March 31,                March 31,
                                             -------------------     -------------------
                                              1999        1998        1999        1998
                                             -------     -------     -------     -------
                                           (unaudited) (unaudited) (unaudited) (unaudited)
<S>                                        <C>         <C>         <C>         <C>
Net sales                                    $ 9,824     $ 8,509     $28,091     $24,434
Cost of sales                                  2,173       1,945       6,384       5,781
                                             -------     -------     -------     -------
Gross profit                                   7,651       6,564      21,707      18,653
Operating expenses:
    Sales and marketing                        3,030       2,667       8,572       7,785
    Research and development                   2,175       2,052       6,461       5,742
    General and administrative                   786         721       2,315       1,943
                                             -------     -------     -------     -------
        Total operating expenses               5,991       5,440      17,348      15,470
                                             -------     -------     -------     -------

Income from operations                         1,660       1,124       4,359       3,183
Other income, net                                247         232         809         477
                                             -------     -------     -------     -------
Income before provision for income taxes       1,907       1,356       5,168       3,660
Provision for income taxes                       648         522       1,821       1,409
                                             -------     -------     -------     -------
Net income                                   $ 1,259     $   834     $ 3,347     $ 2,251
                                             =======     =======     =======     =======

Basic net income per share (Note 3)
                                             $  0.24     $  0.16     $  0.63     $  0.59
                                             =======     =======     =======     =======

Basic weighted average common shares
  (Note 3)                                     5,306       5,367       5,282       3,830
                                             =======     =======     =======     =======

Diluted net income per share (Note 3)        $  0.23     $  0.15     $  0.62     $  0.45
                                             =======     =======     =======     =======

Diluted weighted average common shares
  (Note 3)                                     5,474       5,486       5,412       4,957
                                             =======     =======     =======     =======

</TABLE>




The accompanying notes are an integral part of these condensed consolidated
financial statements.




                                       4


<PAGE>   5

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY
                 Condensed Consolidated Statements of Cash Flows
                                 (in thousands)

<TABLE>
<CAPTION>
                                                                      Nine Months Ended 
                                                                           March 31,
                                                                   ------------------------- 
                                                                      1999          1998
                                                                   ----------     ----------
                                                                   (unaudited)   (unaudited)
<S>                                                                <C>           <C>
Cash flows from operating activities:
    Net income                                                      $  3,347      $  2,251
    Adjustments to reconcile net income to net cash provided by
       operating activities:
          Depreciation and amortization                                1,018         1,153
          Changes in operating assets and liabilities:
              Accounts receivable                                        155        (1,046)
              Inventory                                                 (204)          149
              Other current assets                                      (571)         (135)
              Accounts payable                                            47            59
              Other current liabilities                                1,466         1,196
                                                                    --------      --------
                 Net cash provided by operating activities             5,258         3,627
                                                                    --------      --------


Cash flows from investing activities:
    Purchases of property and equipment                                 (649)         (899)
    Decrease in other assets                                             175            99
    Purchase of short-term investments                                (1,124)         (294)
                                                                    --------      --------
                 Net cash used in investing activities                (1,598)       (1,094)
                                                                    --------      --------


Cash flows from financing activities:
    Principal payments on notes payable                                   --          (821)
    Net proceeds from issuance of common stock                           644        12,643
    Repurchase of common stock                                          (975)           --
                                                                    --------      --------
                 Net cash provided by (used in) financing
                   activities                                           (331)       11,822
                                                                    --------      --------


Net increase in cash and cash equivalents                              3,329        14,355
Cash and cash equivalents, beginning of period                        16,522           801
                                                                    --------      --------
Cash and cash equivalents, end of period                            $ 19,851      $ 15,156
                                                                    ========      ========

Supplemental disclosure of cash flow information:
    Interest paid                                                   $      0      $     27
                                                                    ========      ========
    Income taxes paid                                               $  1,146      $    865
                                                                    ========      ========
</TABLE>


Noncash Activity - During the nine months ended March 31, 1998, the Company
converted 2,667,002 shares of outstanding convertible redeemable preferred stock
into common stock which resulted in a $4,090 increase in common stock and the
reversal of $3,140 of previously accreted cumulative dividends in arrears.

The accompanying notes are an integral part of these condensed consolidated
financial statements.


                                       5

<PAGE>   6

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)

1.    BASIS OF PRESENTATION

The condensed consolidated financial statements of Kofax Image Products, Inc.
and subsidiary (the "Company") presented herein have been prepared pursuant to
the rules of the Securities and Exchange Commission for quarterly reports on
Form 10-Q and do not include all of the information and note disclosures
required by generally accepted accounting principles. These statements should be
read in conjunction with the audited consolidated financial statements and notes
thereto for the year ended June 30, 1998, included in the Company's Annual
Report on Form 10-K for the year ended June 30, 1998.

The condensed consolidated financial statements and notes herein are unaudited,
but in the opinion of management, include all the adjustments (consisting only
of normal, recurring adjustments) necessary to present fairly the consolidated
financial position, results of operations and cash flows of the Company and its
subsidiary. The results of operations for the interim periods shown herein are
not necessarily indicative of the results to be expected for any future interim
period or for the entire year.

2.  INVENTORIES

Inventories, which include material, labor and manufacturing overhead, are
stated at the lower of cost (first-in, first-out) or market and consist of the
following:

<TABLE>
<CAPTION>
                           MARCH 31, 1999     JUNE 30, 1998
                           --------------     -------------
<S>                        <C>                <C>
Raw materials                 $  648              $  827
Work-in-process                  791                 511
Finished goods                   330                 227
                              ------              ------
                              $1,769              $1,565
                              ======              ======
</TABLE>

3.  NET INCOME PER SHARE AND DILUTED NET INCOME PER SHARE

Effective December 27, 1997, the Company adopted SFAS No. 128, "Earnings per
Share," which changes the method used to calculate earnings per share. The new
requirements include a calculation of basic earnings per share, from which the
dilutive effect of stock options is excluded, and a calculation of diluted
earnings per share. Prior period quarterly earnings per share have been restated
in accordance with SFAS No. 128.

The Company believes that diluted net income per share provides the most
meaningful comparison between periods.

4.  CHANGES IN ACCOUNTING PRINCIPLES

Effective July 1, 1998, the Company adopted Statement of Financial Accounting
Standards No. 130, "Reporting Comprehensive Income". This statement requires
that all items recognized under accounting standards as components of
comprehensive earnings be reported in an annual financial statement that is
displayed with the same prominence as other annual financial statements. This
statement also requires that an entity classify items of other comprehensive
earnings by their nature in an annual financial statement. Annual financial
statements for prior periods will be restated, as required. There is no




                                       6


<PAGE>   7

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)



difference between net income and comprehensive income for the third quarter and
nine months ended March 31, 1999.

Effective July 1, 1998, the Company adopted Statement of Position 97-2,
"Software Revenue Recognition". In prior periods the Company recognized software
revenue in accordance with AICPA Statement of Position 91-1. Statement of
Position 97-2 has not had a material effect on the Company's revenue recognition
policies.

5.  RECENT ACCOUNTING PRONOUNCEMENTS

For the years beginning after July 1, 1998, the Company will adopt SFAS No. 131,
"Disclosures about Segments of an Enterprise and Related Information." SFAS No.
131 established standards for the manner in which public companies report
information about operating segments in annual financial statements issued to
shareholders. The Company does not currently have separate operating segments,
and has not yet determined the manner in which it will present the information
required by SFAS No. 131.

In June 1998, the Financial Accounting Standards Board (FASB) issued Statement
of Financial Accounting Standards (SFAS) No. 133, "Accounting for Derivative
Instruments and Hedging Activities", which is effective for all fiscal years
beginning after June 15, 1999. SFAS 133 establishes accounting and reporting
standards for derivative instruments, including certain derivative instruments
embedded in other contracts and for hedging activities. Under SFAS 133, certain
contracts that were not formerly considered derivatives may now meet the
definition of a derivative. The Company intends to adopt SFAS 133 July 1, 1999.
Management does not expect the adoption of SFAS 133 to have a significant impact
on the financial position or results of operations of the Company because the
Company does not have any current derivative activity.



                                       7


<PAGE>   8

                    KOFAX IMAGE PRODUCTS, INC. AND SUBSIDIARY

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
         RESULTS OF OPERATIONS

The discussion in this Form 10-Q contains trend analysis and other
forward-looking statements regarding the Company, its business, prospects and
results of operations that are subject to certain risks and uncertainties posed
by many factors and events that could cause the Company's actual business,
prospects and results of operations to differ materially from those that may be
anticipated by such forward-looking statements. Factors that could cause or
contribute to such differences include, but are not limited to, (i) uncertainty
of future operating results, (ii) fluctuations in quarterly operating results,
(iii) dependence on a limited number of products for current and future
operating results, (iv) dependence on imaging, workflow and document management
market and component software strategy, (v) rapid technological change, (vi) the
impact of competition, (vii) dependence on intellectual property and proprietary
rights, (viii) risks associated with international sales, (ix) dependence on
scanner manufacturers, (x) risks associated with acquisitions, and (xi) the
ability to recruit and retain qualified personnel, as well as those discussed
under the caption "Factors That May Affect Future Operating Results" in the
Company's Annual Report on Form 10-K for the year ended June 30, 1998. Readers
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this report. Readers are urged to carefully
review and consider the various disclosures made by the Company in this report
and in the Company's other reports filed with the Securities and Exchange
Commission that attempt to advise interested parties of the risks and factors
that may affect the Company's business.

OVERVIEW

Kofax Image Products was founded in 1985 to develop image processing accelerator
boards for personal computers to facilitate high-speed scanning, compression,
manipulation and printing of document images. The products were targeted at the
emerging market of document image processing.

Today Kofax develops, markets and supports three product lines for imaging,
workflow and document management applications. The fastest growing products are
the Ascent software applications which manage the capture and long-term storage
of documents for production level workflow and document management systems.
Substantially all of the Company's revenue growth in fiscal years 1998 and 1997
was generated from the Company's Ascent software business. The original image
processing hardware and development tools business, which is in its fourth
generation, currently generates gross margins of approximately 70% and continues
to generate a significant portion of the Company's profits. Revenue from the
Company's family of image processing boards and development tools has grown
modestly over the past two years, and the Company expects that to continue for
the foreseeable future. The Company believes that the accelerator board and
development tools business will continue to account for a majority of the
Company's net sales for the next two to three years. The Company also expects
that its Ascent software products will contribute an increasing share of the
Company's net sales in the future.

The Company sells its products primarily through a two-tier channel of stocking
distributors and solution providers, such as system integrators and value-added
resellers (VARs). The Company typically ships its products within 



                                       8




<PAGE>   9

a short period after acceptance of purchase orders from distributors and other
customers. Accordingly, the Company typically does not have a material backlog
of unfilled orders at the end of any quarter. Revenues from hardware and
software sales are currently recognized at the time of shipment in accordance
with AICPA Statement of Position 97-2, Software Revenue Recognition.
Distributors have certain rights of return and exchange privileges. The
Company's distributors generally do not stock significant amounts of inventory
of the Company's products, as these products are typically incorporated by
resellers into complete imaging and document management systems which are
configured shortly before scheduled delivery to end-user customers. The Company
records estimates for such rights of return and exchange privileges based on
historical experience. The Company provides a warranty for its products against
defects in materials and workmanship. A provision for estimated warranty costs
is recorded at the time of sale. Payments under maintenance contracts are due at
the beginning of the contract; however, revenue is recognized ratably over the
term of the contract which is typically twelve months.



                                       9



<PAGE>   10

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 1999 AND 1998, AND
THE NINE MONTHS ENDED MARCH 31, 1999 AND 1998

The following table sets forth certain income and expense items as a percentage
of net sales for the periods indicated.

<TABLE>
<CAPTION>
                                              Three Months Ended    Nine Months Ended
                                                   March 31,            March 31,
                                              ------------------    ------------------
                                               1999       1998       1999       1998
                                               ----       -----      -----      -----
<S>                                            <C>        <C>        <C>        <C>
Net sales                                      100.0%     100.0%     100.0%     100.0%
Cost of sales                                   22.1       22.9       22.7       23.7
                                               -----      -----      -----      -----
Gross profit                                    77.9       77.1       77.3       76.3
Operating expenses:
    Sales and marketing                         30.9       31.3       30.6       31.9
    Research and development                    22.1       24.1       23.0       23.5
    General and administrative                   8.0        8.5        8.2        7.9
                                               -----      -----      -----      -----
        Total operating expenses                61.0       63.9       61.8       63.3
                                               -----      -----      -----      -----
Income from operations                          16.9       13.2       15.5       13.0
Other income, net                                2.5        2.7        2.9        2.0
                                               -----      -----      -----      -----
Income before provision for income taxes        19.4       15.9       18.4       15.0
Provision for income taxes                       6.6        6.1        6.5        5.8
                                               -----      -----      -----      -----
Net income                                      12.8%       9.8%      11.9%       9.2%
                                               =====      =====      =====      =====
</TABLE>


         Net Sales. Net sales represent gross sales less discounts, returns and
adjustments. Net sales were $9.8 million and $8.5 million in the quarters ended
March 31, 1999 and 1998, respectively, an increase of 15.5%. This revenue
increase was primarily attributable to increased sales of the Company's Ascent
application software products, increased sales of the SCSI versions of the
Company's Adrenaline family of image processing accelerator boards and initial
sales of our new OEM VirtualReScan product. Revenues from Ascent software
increased 30% in the March quarter over the same period last year. However,
software revenue associated with our image processing products declined 32%
compared to the same period last year. As a result, total software revenue in
the third quarter increased 16% in absolute dollars, and total software
represented 35% of total revenues for both periods. For the nine months ended
March 31, 1999 and 1998, net sales were $28.1 million and $24.4 million,
respectively, representing an increase of 15.0%. The year-to-date revenue
increase was also attributable to increased sales of the Company's Ascent
application software products and increased sales of the SCSI versions of the
Company's Adrenaline image processing boards.

         International sales (primarily to Western European countries) accounted
for 30.7% and 34.4% of net sales in the quarters ended March 31, 1999 and 1998,
respectively, and 31.9% and 34.1% in the nine months ended March 31, 1999 and
1998, respectively. International sales increased 3.0% and 7.5%, in absolute
dollars, over the same quarter and nine-month periods last year, respectively.
Management expects that the Company's international operations will continue to
provide a significant portion of total net sales; however, international sales
could be adversely affected if the U.S. dollar continues to strengthen against
international currencies. To date the Company has not had any exposure to
foreign currency fluctuations. The adoption of the "Euro" by the European
community in January 1999 may lead the Company to transact its European sales in
Euros, which may result in the realization of foreign exchange gains or losses
in the future.


                                       10


<PAGE>   11

         Gross Profit. Cost of sales primarily consist of the costs of
components and subassemblies, labor and manufacturing overhead and, with respect
to the Company's software products, software duplication and royalty expenses.
The Company believes that its relatively high gross margins reflect the
increasing percentage of total software revenue in the Company's product mix as
well as the high content of proprietary firmware in the Company's hardware
accelerator boards. Gross profit was 77.9% and 77.1% of net sales in the
quarters ended March 31, 1999 and 1998, respectively, and 77.3% and 76.3% of net
sales in the nine months ended March 31, 1999 and 1998, respectively.
Substantially all of the increase in gross profit percentage in the March
quarter was attributable to a combination of reduction in manufacturing costs
and increased sales volumes allowing fixed manufacturing costs to be spread over
a higher level of production. For the nine months ended March 31, 1999, the
increase in gross profit percentage was attributable to increased sales of the
Company's Ascent software products, the declining costs of components used in
the Company's accelerator boards, and increased overhead absorption as a result
of the improved manufacturing efficiencies mentioned above.

         Sales and Marketing. Sales and marketing expenses, which consist
primarily of salaries and commissions, customer support, trade shows,
advertising and other promotional expenses, were $3.0 million and $2.7 million,
and 30.9% and 31.3% of net sales, in the quarters ended March 31, 1999 and 1998,
respectively. Sales and marketing expenses were $8.6 million and $7.8 million,
and 30.6%, and 31.9% of net sales, in the nine months ended March 31, 1999 and
1998, respectively. The increases in absolute dollar amounts in fiscal 1999 were
primarily attributable to increased marketing personnel, and increased marketing
expenses related to the launch of the Version 4 release of Ascent Storage, and
the launch of the Version 3 release of Ascent Capture. The Company expects that
sales and marketing expenses will continue to increase in absolute dollar
amounts and will fluctuate as a percentage of net sales.

         Research and Development. Research and development expenses, which
consist primarily of personnel costs and related occupancy expenses, were $2.2
million and $2.0 million, and 22.1% and 24.1% of net sales, in the quarters
ended March 31, 1999 and 1998, respectively. Research and development expenses
were $6.5 million and $5.7 million, and 23.0% and 23.5% of net sales, in the
nine months ended March 31, 1999 and 1998, respectively. The increase in
absolute dollars in both periods of fiscal 1999 was primarily attributable to
increased engineering staffing, and related compensation expense. The Company
expects that research and development expenses will continue to increase in
absolute dollar amounts and will fluctuate as a percentage of net sales,
depending upon the timing of material research and product development projects.

         General and Administrative. General and administrative expenses consist
of personnel costs for administration, finance, information systems, human
resources and general management, as well as professional services. General and
administrative expenses were $0.8 million and $0.7 million, and 8.0% and 8.5% of
net sales, in the quarters ended March 31, 1999 and 1998, respectively. General
and administrative expenses were $2.3 million and $1.9 million, and 8.2% and
7.9% of net sales, in the nine months ended March 31, 1999 and 1998,
respectively. The increases in both periods of fiscal 1999 were primarily
attributable to increased staffing and related compensation expenses and the
increased expenses related to the administrative requirements of being a public
company. The Company anticipates that it will continue to incur 



                                       11


<PAGE>   12

increased general and administrative costs in the future related to the
additional insurance and administrative requirements of a public company.

         Other Income, net. Other Income, net consists primarily of interest
income earned on the Company's cash and cash equivalents and short-term
investments less interest expense on the Company's note payable. As a result of
the initial public offering of the Company's stock in the December 1997 quarter,
interest expense on bank borrowing was eliminated due to repayment of the
previously outstanding bank term loan. Interest income increased compared to the
same periods last year, as a result of investing the net proceeds from the
offering and investing the net cash flows generated from the Company's
operations.

         Provision for Income Taxes. The Company's effective tax rate was 34%
for the quarter ended March 31, 1999 compared to 38.5% for the same quarter in
1998. The decline in the effective tax rate results from the recent extension of
the federal R&D tax credit through June 30, 1999. The Company expects the
effective tax rate to approximate 35% for the fiscal year June 30, 1999. The
Company also expects the effective tax rate to return to historical levels of
approximately 38% in fiscal year 2000, unless the current R&D tax credit is
extended in its current form.

         Year 2000 Issues. It is possible that the currently installed computer
systems, software products or other business systems of the Company's
distributors, resellers, suppliers, manufacturers or customers, working either
alone or in conjunction with other software systems, will not accept input of,
store, manipulate and output dates in the Year 2000 or thereafter without error
or interruption (the "Year 2000 Problem"). The Company has tested its software
products and is unaware of any material Year 2000 Problems. In addition, the
Company has completed a review of its business systems, including its computer
systems, and based on information gathered to date, believes that such systems
are also not subject to any material Year 2000 Problems. The Company is querying
its distributors, resellers, suppliers, manufacturers and customers as to their
progress in identifying and addressing Year 2000 Problems. The Company's primary
distributors, resellers, suppliers, manufacturers, and customers have indicated
that they are Year 2000 compliant. Based on the Company's review of its products
and business systems and responses from its significant third party vendors, the
Company believes that total costs due to the Year 2000 Problem will not exceed
$100,000. The failure of the Company or its distributors, resellers, suppliers,
manufacturers and customers to complete the conversions or upgrades necessary to
fully address the Year 2000 Problem in a timely manner could have material
adverse effect on the Company's business, results of operations, cash flows and
financial condition.

The Company's past operating results have been, and its future operating results
will be, subject to fluctuations due to a number of factors, including the
timing of orders from, and shipments to, major customers; the timing of new
product introductions by the Company or its competitors; variations in the mix
of products sold by the Company; changes in pricing policies by the Company, its
competitors or suppliers, including possible decreases in average selling prices
of the Company's products in response to competitive pressures; product returns
or price protection charges from customers; market acceptance of new and
enhanced versions of the Company's products; the availability and cost of key
components; the availability of manufacturing capacity; delays in the
introduction of new products or product enhancements by the Company, the
Company's competitors or other providers of hardware, software and components




                                       12


<PAGE>   13

for the imaging, workflow and document management market; dependence upon
capital spending budgets; and fluctuations in general economic conditions. As a
result, the Company believes that period-to-period comparisons of its results of
operations should not be relied upon as indications of future performance.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 1999, combined cash, cash equivalents, and short-term
investments totaled $25.3 million, an increase of $4.5 million from June 30,
1998. Net cash provided by operating activities was $5.3 million, and was
generated primarily from net income, depreciation and amortization, and an
increase in other current liabilities. Net cash used in investing activities was
$1.6 million for capital expenditures and additions to short term investments.
Net cash used in financing activities was $0.3 million, primarily as a result of
the repurchase of 150,000 shares of the Company's common stock.

The Company financed its operations and capital requirements from 1986 through
1989 from the sale of approximately $4.0 million of preferred stock and,
thereafter, through cash flow from operations. In October 1997, the Company
completed its initial public offering selling 1,300,000 shares of its common
stock, and received net proceeds, after subtracting expenses incurred in the
offering, of approximately $12.6 million, $0.7 million of which was used to
repay outstanding indebtedness.

The Company has an unsecured $2.0 million revolving credit line with Silicon
Valley Bank (the "Bank") and as of March 31, 1999 had no outstanding balance
under the revolving line of credit. In January, 1999, the Company entered into
an agreement with the Bank to extend the line of credit through January, 2000.
The line of credit agreement requires the Company to maintain its primary
banking relationship with the Bank while any obligations to the Bank remain
outstanding, prohibits the incurrence of additional debt from sources other than
the Bank, except for purchases or leases of equipment up to $700,000, requires
the Company to maintain certain tangible net worth levels, and profitability
levels, and restricts the payment of dividends without the Bank's prior
approval.

On April 24, 1998, the Company's board of directors authorized a program for
repurchase of up to 500,000 shares, or approximately 9.5%, of Kofax's
outstanding common stock, to be used to fund stock option exercises, employer
equity compensation plans, and an employee stock purchase plan. As of March 31,
1999, the Company has repurchased 250,000 shares of its common stock to date,
for approximately $1.6 million. Aside from this program, the Company currently
has no significant capital spending or purchase commitments other than normal
purchase commitments and commitments under facilities leases.

The Company believes that its existing cash balances, its available bank
financing and the cash flows generated from operations, if any, will be
sufficient to meet its anticipated cash needs for working capital and capital
expenditures for at least the next 12 months. A portion of the Company's cash
could be used to acquire or invest in complementary businesses or products or
obtain the right to use complementary technologies. The Company is currently
evaluating, in the ordinary course of business, potential investments such as
businesses, products or technologies.




                                       13


<PAGE>   14

Quantitative and Qualitative Disclosures about Market Risk

At March 31, 1999, the Company had an investment portfolio of fixed income
securities, including those classified as cash equivalents, of approximately
$24.5 million. These securities are subject to interest rate fluctuations. An
increase in interest rates could adversely affect the market value of the
Company's fixed income securities.

As of March 31, 1999, the weighted average maturity of the Company's portfolio
was 139 days. The market value changes for increases in short-term treasury
security yields are not material due to the overall short-term maturity of the
Company's portfolio.

The Company limits its exposure to interest rate and credit risk by establishing
and strictly monitoring clear policies and guidelines for its fixed income
portfolios. At the present time, the maximum average maturity of the Company's
overall investment portfolio is limited by policy to 36 months. The guidelines
also establish credit quality standards, limits on exposure to one issue,
quality standards for issuers, as well as the type of instrument. Due to the
limited duration and credit risk criteria established in the Company's
guidelines, the exposure to market and credit risk is not expected to be
material. The Company does not use derivative financial instruments in its
investment portfolio to manage interest rate risk.






                                       14


<PAGE>   15

                           PART II - OTHER INFORMATION

ITEM 3. LEGAL PROCEEDINGS

On September 26, 1997, VisionShape, Inc. ("VisionShape") filed suit against the
Company in the Superior Court of Orange County, California. VisionShape claims
that the Company's Adrenaline accelerator boards prevent the use of software
other than the Company's software, which, the complaint alleges, creates a
monopoly or otherwise constitutes a tying arrangement in violation of state and
federal antitrust laws. VisionShape seeks unspecified monetary damages and costs
as well as equitable remedies, including an order enjoining the Company from
selling its Adrenaline accelerator boards. VisionShape also seeks treble damages
and attorneys' fees. On May 27, 1998, the Superior Court held that VisionShape
failed to state a cause of action against the Company and ordered the suit
dismissed on July 15, 1998. VisionShape filed an appeal on March 31, 1999. Based
upon information currently available to the Company, the Company believes
VisionShape's claims are without merit and intends to contest vigorously any
action against the Company. However, it is too early to determine the outcome of
such appeal and there can be no assurance as to the eventual outcome of such
actions. Any determination against the Company in the litigation or the
settlement of such claims could have a material adverse effect on the Company's
business, results of operation, cash flows and financial condition. The Company
is not a party to any other material legal proceedings.


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits

    10.32   Silicon Valley Bank Amendment to Loan and Security Agreement dated
            January 6, 1999.

    10.33   OEM Purchase Agreement, dated January 27, 1999, between the
            Company and Fujitsu Computer Products of America, Inc.

    11.1    Computation of diluted net income per share

    27.1    Financial Data Schedule

(b) Reports on Form 8-K

    None.

Items 1, 2, 4, and 5 are not applicable and have been omitted.


                                       15

<PAGE>   16

                                   SIGNATURES

         Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.


                                                    KOFAX IMAGE PRODUCTS, INC.


Dated:   May 14, 1999                               /s/ Ronald J. Fikert
                                                    ----------------------------
                                                    Ronald J. Fikert
                                                    Chief Financial Officer
                                                    (principal financial and 
                                                    accounting officer and
                                                    duly authorized officer)





                                       16


<PAGE>   17


                                 EXHIBIT INDEX
                                 -------------


EXHIBIT
INDEX           DESCRIPTION
- -------         -----------

10.32           Silicon Valley Bank Amendment to Loan and Security Agreement 
                dated January 6, 1999.

10.33           OEM Purchase Agreement, dated January 27, 1999, between the
                Company and Fujitsu Computer Products of America, Inc.

11.1            Computation of diluted net income per share

27.1            Financial Data Schedule






<PAGE>   1
                                                                   EXHIBIT 10.32

- --------------------------------------------------------------------------------


SILICON VALLEY BANK

                         AMENDMENT TO LOAN AND SECURITY
                                    AGREEMENT

BORROWER:      KOFAX IMAGE PRODUCTS, INC.
ADDRESS:       3 JENNER STREET 
               IRVINE, CALIFORNIA 92718

DATED AS OF:   JANUARY 6, 1999

        THIS AMENDMENT TO LOAN AGREEMENT is entered into between SILICON VALLEY
BANK ("Silicon") and the borrower named above (the "Borrower"). The Parties
agree to amend the Loan and Security Agreement between them, dated February 28,
1992, as amended by that certain Amendment to Loan Agreement dated March 9,
1993, as amended by that certain Amendment to Loan Agreement dated October 10,
1994, as amended by that certain Amendment to Loan Agreement dated October 5,
1995, as amended by that certain Amendment to Loan Agreement dated January 20,
1996, as amended by that certain Amendment to Loan Agreement dated October _,
1996, as amended by that Amendment to Loan and Security Agreement dated
September 18, 1997 and as amended by that Amendment to Loan and Security
Agreement dated January 6, 1998 (as so amended and as otherwise amended from
time to time, the "Loan Agreement"), as follows, effective on the date hereof.
(Capitalized terms used but not defined in this Amendment, shall have the
meanings set forth in the Loan Agreement.)

        1.      AMENDED MATURITY DATE. Section 5.1 of The Maturity Date as set
forth in the Schedule to Loan Agreement is amended effective as of the date
hereof, to read as follows:

        "MATURITY DATE (Section 5.1): JANUARY 5, 2000."

        2.      REVISED NEGATIVE COVENANT EXCEPTIONS. . The section of the
Schedule to the Loan Agreement entitled "Negative Covenant-Exceptions (Section
4.6)" is hereby replaced with the following:

        "NEGATIVE COVENANTS-EXCEPTIONS

        (Section 4.6):          Without Silicon's prior written consent,
                                Borrower may do the following, provided that,
                                after giving effect thereto, no Event of Default
                                has occurred and no event has occurred which,
                                with notice or passage of time or both, would
                                constitute an Event of Default, and provided
                                that the following are done in compliance with
                                all applicable laws, rules and regulations: (i)
                                repurchase shares of Borrower's stock provided
                                that the aggregate amount of any such other
                                repurchase shall not exceed $3,500,000; (ii)
                                make loans to, or enter into loan guaranties on
                                behalf of, employees in an aggregate amount not
                                exceeding $200,000 at any one time


                                      -1-
<PAGE>   2
Silicon Valley Bank                     Amendment to Loan and Security Agreement
- --------------------------------------------------------------------------------


                                outstanding; and (iii) make loans to employees
                                in connection with computer purchases ("Employee
                                Computer Loans") provided that the Employee
                                Computer Loans shall not exceed $300,000 in the
                                aggregate at any one time outstanding."

        3.      AMENDED FINANCIAL COVENANTS. The section of the Schedule to Loan
Agreement entitled "Financial Covenants" is amended to read as follows:


        "FINANCIAL COVENANTS
        (Section 4.1):          Borrower shall comply with all of the following
                                covenants. Compliance shall be determined as of
                                the end of each quarter, except as otherwise
                                specifically provided below:

        TANGIBLE NET WORTH:     Borrower shall maintain a tangible net worth of
                                not less than $25,000,000.

        PROFITABILITY:          Borrower shall not incur a loss (after taxes)
                                for any fiscal quarter.

        DEFINITIONS:            "Tangible net worth" means the excess of total
                                assets over total liabilities, determined in
                                accordance with generally accepted accounting
                                principles, excluding however all assets which
                                would be classified as intangible assets under
                                generally accepted accounting principles,
                                including without limitation goodwill, licenses,
                                patents, trademarks, trade names, copyrights,
                                and franchises.

        SUBORDINATED DEBT:      "Liabilities" for purposes of the foregoing
                                covenants do not include indebtedness which is
                                subordinated to the indebtedness to Silicon
                                under a subordination agreement in form
                                specified by Silicon or by language in the
                                instrument evidencing the indebtedness which is
                                acceptable to Silicon."

        4.      NEGATIVE PLEDGE AGREEMENT. Without limitation of any other term
or provision of the Loan Agreement that restricts liens on the assets of the
Borrower, Borrower shall not incur any liens or encumbrances on any of is
property or assets, whether now owned or hereafter acquired, other than security
interests or liens on equipment leased or purchased in connection with such
lease or purchase transaction as otherwise permitted under the Loan Agreement.

        5.      FACILITY FEE. The Borrower shall pay Silicon concurrently
herewith a facility fee in the amount of $5,000, which shall be in addition to
all interest and all other fees payable to Silicon and shall be non-refundable.

        6.      REPRESENTATIONS TRUE. Borrower represents and warrants to
Silicon that all representations and warranties set forth in the Loan Agreement,
as amended hereby, are true and correct as of the date hereof.


                                      -2-
<PAGE>   3
Silicon Valley Bank                     Amendment to Loan and Security Agreement
- --------------------------------------------------------------------------------


        7.      GENERAL PROVISIONS. This Amendment, the Loan Agreement, any
prior written amendments to the Loan Agreement signed by Silicon and the
Borrower, and the other written documents and agreements between Silicon and the
Borrower set forth in full all of the representations and agreements of the
parties with respect to the subject matter hereof and supersede all prior
discussions, representations, agreements and understandings between the parties
with respect to the subject hereof. Except as herein expressly amended, all of
the terms and provisions of the Loan Agreement, and all other documents and
agreements between Silicon and the Borrower shall continue in full force and
effect and the same are hereby ratified and confirmed.

BORROWER:                              SILICON:

KOFAX IMAGE PRODUCTS, INC.             SILICON VALLEY BANK


By  /s/ DAVID S. SILVER                By  /s/ MARLA JOHNSON        
  --------------------------------       -----------------------------------
    President or Vice President        Title  Vice President
                                            --------------------------------


By  /s/ RONALD J. FIKERT    
  --------------------------------
    Secretary or Ass't Secretary


                                      -3-

<PAGE>   1

                                                                   EXHIBIT 10.33


                             OEM PURCHASE AGREEMENT
                                     BETWEEN
                   FUJITSU COMPUTER PRODUCTS OF AMERICA, INC.
                                       AND
                           KOFAX IMAGE PRODUCTS, INC.

This Agreement is made and entered as of January 27, 1999 ("Effective Date") by
and between KOFAX IMAGE PRODUCTS, INC. ("KOFAX") located at 3 Jenner Street,
Irvine, CA 92618 and FUJITSU COMPUTER PRODUCTS OF AMERICA, INC.
("FCPA") located at 2904 Orchard Parkway, San Jose, CA 95134.

WHEREAS, KOFAX has developed VRS Products ("Products") as described in Exhibit A
and FCPA wishes to purchase Products and incorporate such Products into FCPA's
M-series scanner line to be resold to FCPA's customers, which include original
equipment manufacturer ("OEM") and Distribution customers. KOFAX and FCPA,
therefore, desire to enter into an OEM purchase agreement (The "Agreement") for
the VRS Products.

In consideration of the mutual promises and covenants of the parties hereto and
other valuable consideration, the parties hereby agree with each other as
follows:

1.      DEFINITIONS

        As used in this Agreement, the following words shall have only the
        following meanings:

        (a)     "Product(s)" shall mean the VRS Products, conforming to the
                specifications ("Specifications") attached hereto as 
                Exhibit A.

        (b)     "Order" shall mean a written purchase Order signed by FCPA and
                sent by FCPA to KOFAX by mail or facsimile.

        (c)     "Deliver" and "Delivery" shall mean to transfer by KOFAX to
                FCPA's, designated carrier.

2.      TERM

        This Agreement shall be effective as of the Effective Date and shall
        continue in effect for an initial term of one (1) year. Thereafter, it
        will renew in one (1) year increments unless terminated pursuant to the
        provisions herein.

3.      PURCHASE ORDERS

        (a)     FCPA shall purchase the Products pursuant to written Orders that
                will be submitted by FCPA by the twentieth (20th) day of each
                month.


                                  Page 1 of 28
<PAGE>   2

        (b)     The Terms of this Agreement prevail over any pre-printed
                conditions appearing on any form. The printed conditions
                appearing on any pre-printed form or purchase Order shall not be
                applied if they are incompatible with the provisions of this
                Agreement. Each written Order placed by FCPA pursuant to this
                Agreement shall state that it is subject to the terms of this
                Agreement, shall identify the Products Ordered and shall include
                the following information:

                (i)     Description of the Products Ordered using FCPA's
                        assigned Product number and KOFAX's assigned part
                        number;

                (ii)    Quantities and requested Delivery schedule;

                (iii)   Shipping instructions including assigned carrier and
                        destination address;

        (c)     If an Order is sent by facsimile, the Order shall be followed by
                the original sent by mail.

        (d)     KOFAX shall deliver Products to FCPA pursuant to a written Order
                accepted and acknowledged by KOFAX in accordance with the
                requested Delivery schedule. Lead time required for Delivery is
                sixty (60) days from the date of KOFAX's acceptance of each
                Order for normal Orders. FCPA shall have three (3) business days
                in which to notify KOFAX that the acknowledged Delivery dates
                not meet FCPA's requirements and KOFAX shall use commercially
                reasonable efforts to reschedule the Order for an earlier date
                as mutually agreed between the parties. FCPA may cancel, without
                penalty any Order delayed in excess of sixty (60) days beyond
                the acknowledged Delivery date.

        (e)     Any Order given by FCPA will be deemed accepted by KOFAX unless
                it is rejected by KOFAX within two (2) working days after KOFAX
                receives it. KOFAX shall be obligated to accept Orders that
                conform to, but do not exceed by twenty-five percent (25%) any
                forecast provided by FCPA. Upon such acceptance, each Order
                shall constitute an individual contract for the transaction of
                Products Ordered. KOFAX shall provide a written acknowledgement
                for each Order showing acknowledged Delivery dates, quantities
                and pricing.

        (f)     In the case of Orders that do exceed by twenty-five percent
                (25%) any forecast provided by FCPA, the agreement of KOFAX is
                required before such Order shall be deemed to be accepted.

        (g)     Unless mutually agreed, Orders for Products shall not exceed the
                rolling forecast by more than twenty-five percent (25%).

        (h)     If KOFAX expects to ship Products late, Products shall be
                shipped via next day airfreight. The difference between
                airfreight and normal freight charges will be paid for by
                KOFAX, if Products arrive at KOFAX on or before the Order due
                date. However, if the Products arrive at KOFAX after the Order
                due date, the expense for air freight shall be paid for by
                KOFAX.


                                  Page 2 of 28
<PAGE>   3

4.      BUFFER STOCK

        KOFAX will maintain a buffer stock amount of Products to be ordered
        under this Agreement equal to two (2) weeks in inventory and one (1)
        week in transit according to the then current rolling forecast. This
        buffer stock will be considered consigned for FCPA and will be purchased
        upon termination of this Agreement as defined in Section 30.

5.      EMERGENCY ORDERS

        KOFAX shall maintain a stock of Product for emergency Product Orders at
        a quantity to be determined mutually between KOFAX and FCPA.

        Emergency Orders of Products shall be delivered within twenty-four (24)
        hours of receipt of such Order, provided such Products are available
        from KOFAX. If necessary KOFAX may pull Product for emergency Orders
        from the buffer stock provided KOFAX uses reasonably commercial efforts
        to replenish the buffer stock immediately. Emergency Orders are deemed
        to be those Orders in which a Product is needed immediately because of a
        service related issue and not for fulfillment purposes.

6.      FORECAST

        By the twentieth (20th) day of each month, FCPA will provide a
        non-binding six (6) month rolling forecast to KOFAX.

7.      CHANGE/CANCELLATION OF ORDER

        (a)     Orders accepted by KOFAX may be modified or cancelled by FCPA
                with written notice to KOFAX thirty (30) calendar days prior to
                the acknowledged date of shipment. If such Orders cancelled less
                than sixty (60) days prior to the acknowledged ship date may be
                subject to reimbursement of the raw materials that are
                associated with the Product that cannot be re-used or re-sold by
                KOFAX, and provided such cost for raw materials do not exceed
                the then current price of the Product. Should KOFAX develop and
                sell other VRS products that also use the raw materials listed
                below, KOFAX will identify and remove those raw materials from
                the list. The list of raw materials subject to reimbursement at
                the time of execution of this Agreement are as follows:

                        Part Number               Description

                        12000162-000              PCB FUJI INTERNAL SCA
                        14001018-000              CAP .33uF 50V 20% 805
                        14350045-000              RES 22 OHM, 1/8W 5% 8
                        14350047-000              RES NTWK 2.2K OHM 1/8
                        14350048-000              RES NTWK 22 OHM 1/8W
                        15250764-000              IC 74FCT162245 SSOP 4
                        15501009-000              IC DS229S TRNSM/RCVR
                        15603037-000              IC PROG QUAIL 3 MACH 1


                                  Page 3 of 28
<PAGE>   4

                        15701022-000              IC FIFO MEM 5Kx8 SOIC
                        15701023-000              IC FIFO MEM 10Kx8 TSO
                        15701025-000              IC SDRAM 4X16 TSOP 54
                        15701030-000              IC PROG FLASH ROM 256
                        15800046-001              IC DS1233DZ-10 SOT
                        15800050-002              IC RISK CNTLR MCF5206
                        15801029-000              IC FPGA 10K30A 208PQF
                        15801028-000              IC ALTERA 6024A 3.3V
                        15901005-000              IC ASIC DESKEW 208PQF
                        16100008                  CONN 37 PIN FEMALE DS
                        16100063-002              HEADER2X5SMT
                        16100066-000              CONN 44 PIN DIN MALE
                        16120005                  SHUNT JUMPER

                There will be no cancellation or reimbursement fees applicable
                to orders cancelled more than sixty (60) days prior to the
                acknowledged ship date.

        (b)     Deliveries may be rescheduled one time per Order up to 100% with
                fifteen (15) days written notice from FCPA.

8.      DELIVERY TERMS

        Delivery terms shall be FOB Irvine, California. KOFAX shall use its best
        effort to ship the Product according to FCPA's then current freight
        routing guide, a copy of which is attached as Exhibit G. Title to and
        risk of loss of all Products purchased by FCPA hereunder shall pass from
        KOFAX to FCPA upon Delivery.

9.      PACKAGING

        All packaging materials and methods shall be KOFAX's standard commercial
        materials and/or the methods set forth in Exhibit B. If FCPA requests
        any special packaging materials or methods different from those noted
        above, and if KOFAX agrees to use such special materials or methods, the
        additional cost thereof shall be paid by FCPA. If FCPA and KOFAX agree
        that the standard packaging is inadequate, then KOFAX will implement
        improved packaging at no extra cost to FCPA.

10.     LABELING

        Labeling shall be designed in accordance with the specifications set
        forth in Exhibit B entitled Product Requirements.


11.     PRICES

        (a)     The price to be paid by FCPA to KOFAX for the Product is
                attached as Exhibit C.


                                  Page 4 of 28
<PAGE>   5

        (b)     KOFAX warrants that the price and terms set forth herein do not
                exceed those charged or imposed on any other customer
                purchasing the same Product for like quantities, terms and
                conditions.

        (c)     If KOFAX lowers its prices for the Product that meet the pricing
                requirements summarized in paragraph 11 (b) during the term of
                the Agreement; KOFAX shall immediately extend such lower prices
                to FCPA. If KOFAX decreases the price of any Product purchased
                by FCPA and still in FCPA's inventory, FCPA will be entitled to
                a credit on Products delivered to and paid for by Distributor,
                less any prior credits granted by FCPA, in the amount of the
                purchase price less the new decreased price for the Products
                multiplied by the quantity of such Products in FCPA's inventory
                on the effective date of the price decrease. Similar price
                adjustment will also be made on (i) all such Products in transit
                to FCPA on the effective date of such price decrease, and (ii)
                all Orders for such Products previously accepted by KOFAX but
                remaining unshipped on the effective date of such price
                decrease.

        (d)     Upon reasonable notice and during normal working hours, FCPA may
                appoint an independent auditor to review KOFAX records to
                determine if FCPA is receiving pricing as agreed to hereunder
                and that KOFAX is complying with the terms of this Agreement.
                KOFAX shall allow such independent auditor access to all
                applicable records of KOFAX for the purpose of conducting such
                audit. The independent auditor shall only report to FCPA whether
                KOFAX is complying with the terms of this Agreement.

        (e)     KOFAX will engage in ongoing cost reduction efforts, and where
                practicable, KOFAX will pass price reductions on to FCPA.

12.     PAYMENT

        (a)     All payment for the Products shall be made in U.S. Dollars.

        (b)     Payment will be Net 45 days from date of invoice.

        (c)     FCPA shall be responsible for the payment of all taxes, tax
                levies, or tax assessments imposed on the subject transactions
                or Products. FCPA shall be responsible for providing in a timely
                manner all documentation, in the nature of exemption
                certificates or otherwise, necessary to allow KOFAX to refrain
                from collections, such as sales tax, it is otherwise obligated
                to make. FCPA's obligations shall survive the termination of
                this Agreement.

13.     STOCK ROTATION

        FCPA shall be eligible to rotate Product stock in its inventory for new
        Product which has been upgraded to a new version of VRS, provided such
        new version of the Product affects the form, fit or function of the
        preceding version, under the following terms:


                                  Page 5 of 28
<PAGE>   6

        (a)     FCPA shall be eligible for, subject to full compliance with
                Subsections (b) and (c) below, stock rotation privileges for a
                dollar amount of Product not to exceed ten percent (10%) of the
                then current dollar value of Product shipped to FCPA, less any
                credits or returns, for the three month period immediately prior
                to the stock rotation months of April, July, October and
                January. No percentage of rotation allowable shall accrue from
                one period to the next. Credit shall be at the net current value
                of the Product, which is the price paid by FCPA, less any
                credits granted to FCPA.

        (b)     An off-setting, non-cancelable Order for the same dollar amount
                in different Products than those rotated, must be submitted with
                request for stock rotation. Delivery dates scheduled under this
                purchase order shall not exceed thirty (30) days.

        (c)     Product returned for stock rotation must have been purchased
                from KOFAX during the previous six (6) months, be new, unused
                and in factory sealed containers, and be returned to KOFAX
                freight prepaid.

14.     TRADEMARK

        (a)     All Products purchased by FCPA from KOFAX under this Agreement
                shall be used, leased, rented, licensed or sold by FCPA only
                under trademarks and/or trade names of FCPA or those of FCPA's
                customers or their customers. FCPA shall not use KOFAX's
                trademarks or trade names on or in connection with Products
                except as required by law or governmental regulation or as
                expressly authorized by KOFAX.

        (b)     FCPA grants KOFAX the right and KOFAX agrees to apply FCPA's
                trademarks or those of FCPA's customers to which FCPA has the
                right to have KOFAX apply to the Products (excluding any third
                party software which KOFAX may be licensed to use) to be
                manufactured and delivered to FCPA according to this Agreement,
                but at the expense of FCPA.

        (c)     FCPA agrees to defend KOFAX against any claim of trademark
                infringement by reason of the use upon the Products and/or upon
                any printed material in connection therewith of FCPA's trademark
                and trade names or those of FCPA's customers when so directed by
                FCPA. FCPA shall indemnify and hold harmless against any damages
                and cost reasonably incurred by KOFAX in any such claim to the
                extent attributable to such claim. FCPA's obligations with
                respect to such claims are expressly conditioned upon KOFAX
                giving FCPA prompt notice of any such claim and granting FCPA in
                writing exclusive control over its defense or settlement and
                cooperation with FCPA in the defense of such claim at FCPA's
                expense.

        (d)     KOFAX agrees to defend FCPA against any claim of copyright or
                trademark


                                  Page 6 of 28
<PAGE>   7

                infringement by reason of the use upon the Products and/or upon
                any printed material in connection therewith of KOFAX's
                software, trademark and trade names or those of KOFAX's
                customers when so directed by KOFAX. KOFAX shall indemnify and
                hold harmless against any damages and cost reasonably incurred
                by FCPA in any such claim to the extent attributable to such
                claim. KOFAX's obligations with respect to such claims are
                expressly conditioned upon FCPA giving KOFAX prompt notice of
                any such claim and granting KOFAX in writing exclusive control
                over its defense or settlement and cooperation with KOFAX in the
                defense of such claim at KOFAX's expense.

15.     SOFTWARE LICENSE

        (a)     Object License. KOFAX grants FCPA a non-exclusive,
                non-transferable worldwide license to reproduce and distribute
                each Licensed Software (object code form only), for which the
                Licensed Software is to be integrated or adapted, as described
                in Exhibit B.

        (b)     Internal Copies. FCPA may use the Licensed Software internally
                for testing, demonstrating, training, customer support, and
                promotional purposes. No royalty shall be due KOFAX for copies
                of the Licensed Software which have been distributed for
                testing, training, demonstration and promotional purposes.

16.     DOCUMENTATION

                KOFAX hereby grants FCPA the royalty-free right to reproduce,
                use, distribute and sell in FCPA's name all documentation
                associated with the Product under this Agreement. These rights
                with respect to documentation shall extend solely to FCPA.


17.     SHIPPING INSPECTION/ACCEPTANCE

        (a)     KOFAX shall cause inspection of each lot of the Products, prior
                to shipment of such lot to FCPA, and shall provide to FCPA the
                records of such inspection upon written request by FCPA. KOFAX
                at FCPA's request will supply a Certificate of Conformance on
                each lot shipping to FCPA.

        (b)     FCPA may attend and witness or participate in such inspection of
                the Products at the source as made by or for KOFAX, in order to
                determine that the Products conform with the Specifications,
                prior to acceptance of Delivery.

        (c)     FCPA shall have twenty (20) days from the date of receipt of the
                Products to perform incoming inspection and acceptance testing
                on the Products to determine whether the Product performs in
                accordance with the Product Specifications as set forth in
                Exhibit A and in accordance with procedures agreed to between
                the parties.



                                  Page 7 of 28
<PAGE>   8

        (d)     In the event that any Products delivered by KOFAX fail to pass
                such incoming inspection, FCPA shall notify KOFAX of such
                failure specifying the nature of the failure within the twenty
                (20) day acceptance period.

        (e)     Within five (5) business days after receipt of the notice of
                such defective Products, KOFAX shall:

                (i)     Replace such defective Products at KOFAX's expense,

                (ii)    Replace any service parts at KOFAX's own cost, including
                        labor.

18.     WARRANTY/DEFECTIVE PRODUCTS

        (a)     KOFAX warrants that all Products shall meet the Product
                Specifications set forth in Exhibit A and that all Products
                shall be free from material defects in design and workmanship.

        (b)     KOFAX further represents and warrants that KOFAX Products
                purchased under this Agreement will be Year 2000 compliant as
                set forth in Exhibit H and therefore will process date/time data
                during the transition from, into, and between the 20th and 21st
                centuries, provided that the computer system(s) to which the
                Products are connected accurately process the transition from,
                into, and between the 20th and 21st centuries. This warranty
                does not apply to any third-party branded products that may be
                bundled with Products or otherwise distributed by KOFAX.

        (c)     If a Product is found to be defective within ninety (90) days
                from date of Delivery to FCPA, FCPA may return the defective
                Product to KOFAX for credit utilizing the then current RMA
                procedure as set forth in Exhibit D, in the container specified
                by KOFAX, transportation prepaid. Any revisions to the RMA
                Procedure shall be reasonably agreed to by both parties and
                shall be deemed incorporated into this Agreement upon its
                acceptance by FCPA.

        (d)     After the initial ninety (90) day period, should any material
                defect in the Products be discovered by FCPA within the next
                twenty-four (24) months following the Delivery of such Products,
                FCPA shall notify KOFAX in writing of such defect promptly after
                discovery of such defect. In such case, KOFAX shall, within ten
                (10) business days after receipt of the notices of such
                defective Products specifying the nature of the defect, take
                appropriate measures including but not limited to the following
                as reasonably agreed to between FCPA and KOFAX.

                (i)    To supply to FCPA, free of charge, at KOFAX's discretion
                       repair and/or replacement Product of such material
                       defective Products. FCPA will ship back defective
                       Products to a location designated by KOFAX at KOFAX's
                       expense.


                                  Page 8 of 28
<PAGE>   9

                (ii)    To replace such defective Products at KOFAX's expense.

                (iii)   To modify the design of any Products (either delivered
                        or undelivered to FCPA) at KOFAX's expense so as to make
                        them non-defective Products.

        (e)     In the case of Epidemic Failure, KOFAX shall repair or replace
                any Product which does not conform to the foregoing warranties
                set forth herein, including reimbursement of labor incurred by
                FCPA. FCPA will ship back defective parts to a location
                designated by KOFAX in connection with repairing such Products
                at KOFAX's expense and pursuant to its then current RMA
                procedures. Epidemic Failure means any out of specification
                Product or Part failure, resulting from the same cause or
                phenomena, which can be found (i) on a minimum of 5 units per
                shipment and (ii) affects at least 5% of the total shipments
                received by FCPA.

        (f)     The Warranty hereunder shall not apply to any Product:

                (i)     Which has not been operated in accordance with the
                        applicable operators manual, or

                (ii)    Which has not been maintained in accordance with the
                        Product Specifications.

19.     TRAINING

        For a period of ninety (90) days from the Effective Date of this
        Agreement, KOFAX will provide at no charge a reasonable amount of
        initial training, but no less than forty (40) hours of training, to
        corporate FCPA training personnel, sales persons, engineers, and all
        FCPA personnel necessary at the discretion of FCPA. After the initial
        training, FCPA and KOFAX will mutually agree on a training schedule,
        cost and location and FCPA will reimburse for actual per diem expenses
        of KOFAX Personnel. Training shall be adequate and sufficient to acquire
        all necessary information for the Product. Training shall include, at
        KOFAX's expense, the most current Product information, training
        materials updates, upgrades or enhancements to the Product.

20.     PRODUCTS LIABILITY AND INDEMNITY

        (a)     KOFAX will defend at its own expense any suit brought against
                FCPA to the extent that it is based on a claim that Product made
                for FCPA in the form delivered to FCPA, caused damages to
                tangible property or personal injury, including death, of third
                parties provided that (i) FCPA shall notify KOFAX promptly in
                writing of any claim, (ii) KOFAX shall have sole control of the
                defense of any claim and all negotiations for its settlement or
                compromise, and (iii) FCPA shall provide complete authority,
                information, and assistance to KOFAX and its counsel for the
                defense of such claim Subject to subsection (b)


                                  Page 9 of 28
<PAGE>   10

                hereof, KOFAX shall indemnify and hold harmless FCPA against any
                damages finally awarded against FCPA in any such suit to the
                extent attributable to such claim.

        (b)     KOFAX shall have no liability or obligation to FCPA hereunder
                with respect to such claims if the Product was used for other
                than its intended use or if the damages resulted from the gross
                negligence or willful misconduct by the end user. Neither Party
                nor its affiliates shall be liable for indirect, special or
                consequential damages.

        (c)     THE FOREGOING STATES THE ENTIRE LIABILITY OF KOFAX AND ITS
                AFFILIATES WITH RESPECT TO PRODUCTS LIABILITY FOR ANY PRODUCTS
                DELIVERED UNDER THIS AGREEMENT.

21.     REGULATORY AGENCY COMPLIANCE

        KOFAX shall be responsible for obtaining certification of approvals from
        agencies listed in the Specification attached hereto.

22.     INDEPENDENT CONTRACTOR

        KOFAX is an independent contractor, and is not and shall not be deemed
        to be the legal representative or agent of FCPA for any purpose
        whatsoever, and KOFAX is not authorized by FCPA to transact business,
        incur obligations (express or implied), bill goods, or otherwise act in
        any manner in the name or on behalf of FCPA, or to make any promise,
        warranty or representation with respect to the Products or any other
        matter in the name or on behalf of FCPA. FCPA shall have no control over
        the manner of performance of KOFAX except as expressly provided herein.

23.     EXPORT LICENSES

        FCPA agrees that it will not export, directly or indirectly, any
        Products or technical data obtained under this Agreement to any country
        without first obtaining proper governmental licenses and/or approvals.

24.     SUPPORT

        (a)     KOFAX will provide technical information (including technical
                bulletins and tips) to FCPA for support of Products and Parts.
                KOFAX hereby grants FCPA the right to duplicate and distribute
                technical information regarding Products which is not
                proprietary or confidential on an as needed basis with the prior
                approval of KOFAX. If available, KOFAX will provide to FCPA any
                user documentation and/or software (including technical
                information) for Products or similar KOFAX Products so that FCPA
                may use the contents, where applicable and allowable, in
                creating FCPA's user documentation. This does not imply any
                transfer of, and does not expressly transfer any ownership of
                intellectual


                                 Page 10 of 28
<PAGE>   11

                property rights from KOFAX to FCPA.

        (b)     KOFAX will provide reasonable program assistance and technical
                support capable of answering questions and resolving purchasing,
                shipment, billing and technical issues at the KOFAX location
                that processes FCPA's Orders.

        (c)     KOFAX agrees to provide Repair Service for Product during the
                term of this Agreement at a mutually agreed upon price and for a
                minimum period of five (5) years following the last shipment of
                Product hereunder based on raw material availability at the
                price in effect at the time of last shipment. Product provided
                to FCPA under repair service shall be covered by a ninety (90)
                day warranty when the warranty period on the Product has passed.
                KOFAX shall have the option of not repairing Product one (1)
                year after last shipment to FCPA, however, if KOFAX elects to
                exercise this option FCPA will be provided with an alternative
                that is acceptable to FCPA, which such acceptance shall not be
                unreasonably withheld.

        (d)     Product returned to KOFAX for repair shall be repaired and
                updated to the specifications of the original Product and
                updated with the latest Engineering Changes. KOFAX shall use
                commercially reasonable efforts to repair and ship the repaired
                Product back to FCPA within ten (IO) business days from receipt.

        (e)     The VRS Problem Escalation Process, as set forth in the attached
                Exhibit E, will be used as a communication tool between FCPA and
                KOFAX to discuss Product problems and Product enhancement
                requests.

25.     PROPRIETARY INFORMATION

        (a)     During the term of this Agreement each party may acquire
                valuable trade secrets and/or confidential and proprietary
                information of the other party or its affiliates. Confidential
                Information means all confidential and proprietary information
                which is disclosed by one party to the other party, which is
                marked confidential or which is identified in writing to be
                confidential within thirty (30) days after disclosure to the
                receiving party ("Confidential Information").


        (b)     Each party agrees not to use the Confidential Information for
                any purpose whatsoever except for the purpose set forth herein.
                Each party agrees not to disclose the Confidential Information
                to any third person or to its employees or those of its
                affiliates except those employees who have a legitimate need to
                know and who agree to keep such information confidential. Each
                party agrees that it shall protect the confidentiality of, and
                take reasonable steps to prevent disclosure or unauthorized use
                of, the Confidential Information in order to prevent it from
                falling into the public domain or the possession of persons not
                legally bound to maintain its confidentiality, provided that in
                no event shall such party's obligations exceed the standard of
                care taken to protect its own


                                 Page 11 of 28

<PAGE>   12

                confidential information of like importance. Each party will
                promptly advise the other party in writing of any
                misappropriation or misuse by any person of such Confidential
                Information and provide assistance to the injured party in any
                lawsuit related thereto. Each party acknowledges that its
                obligations hereunder survive in accordance with the terms
                hereof, notwithstanding the termination of the business
                relationship of the parties, for a period of five (5) years
                following the last disclosure of Confidential Information by the
                other party hereunder.

        (c)     No copies of any Confidential Information may be made except to
                implement the purposes of this Agreement. Any materials,
                documents, notes, memoranda, drawings, sketches and other
                tangible items containing, consisting of or relating to the
                Confidential Information of a party which are furnished to the
                other party in connection with this Agreement, or are in the
                possession of the other party, and all copies thereof, remain
                the property of the party to which the Confidential Information
                is proprietary and shall be promptly returned to the party
                supplying the same upon a party's request therefor. Nothing
                contained in this Agreement shall be construed as granting any
                rights, by license or otherwise, in any Confidential Information
                except as specified in this Agreement.

        (d)     Each party's obligations under this Agreement shall not apply to
                information which: (a) is known by that party or is publicly
                available at the time of disclosure by the disclosing party to
                the receiving party; (b) becomes publicly available after
                disclosure by the disclosing party to the receiving party
                through no act of either party; (c) is hereafter rightfully
                furnished to the receiving party by a third party without
                restriction as to use or disclosure; (d) is disclosed with the
                prior written consent of the disclosing party; (e) is
                information that was independently developed by the receiving
                party; or (f) is required to be disclosed pursuant to any
                judicial or administrative proceeding, provided that the
                receiving party immediately after receiving notice of such
                action notifies the disclosing party of such action to give the
                disclosing party the opportunity to seek any other legal
                remedies to maintain such information in confidence.

26.     INFRINGEMENT

        (a)     KOFAX warrants that to its knowledge all of the Products
                furnished hereunder do not infringe any patent or copyright or
                other industrial property rights, trademark or tradename of a
                third party. KOFAX shall defend, indemnify and save FCPA and
                it's customers harmless from any loss, damage, cost or liability
                incurred by FCPA as a result of any action or suit based on a
                claim which, if true, would constitute a breach of the foregoing
                warranties (hereinafter "Infringement Claims"), provided,
                however, that KOFAX's said obligation shall be conditioned upon:

                (i)     FCPA's notifying KOFAX of the existence of such action
                        or suit promptly; 

                (ii)    FCPA's giving KOFAX full control of the conduct,
                        including settlement


                                 Page 12 of 28
<PAGE>   13

                        of such action or suit;

                (iii)   FCPA's cooperating with KOFAX, at KOFAX's expense.

        (b)     Following the notification of FCPA defined under Subsection
                26(a)(i), KOFAX will at its own expense, either (i) procure for
                FCPA the right to continue using such Products royalty free,
                (ii) replace such Products to FCPA's reasonable satisfaction
                with non-infringing Products or equivalent quality and
                performance, or (iii) modify such Products so that they become
                non-infringing Products of equivalent quality and performance.
                If KOFAX is unable to provide any of the above alternatives,
                KOFAX must pay FCPA for all units sold to FCPA and then may
                terminate this Agreement by giving a written notice to FCPA. The
                foregoing constitutes the sole remedies available to FCPA and
                it's customers in the event of any such infringement.

27.     INTELLECTUAL PROPERTY RIGHTS

        KOFAX claims all rights, title and interest in the Products delivered by
        KOFAX under this Agreement and in all of KOFAX's patents, trademarks,
        trade names, inventions, copyrights, know-how and trade secrets relating
        to the design and operation of that Product. FCPA agrees that the
        execution of this Agreement does not in any way give FCPA rights to any
        KOFAX' intellectual property or patents. However, should there be any
        work product developed during the term of the Agreement which is a
        result of any intellectual property provided by FCPA, it shall be
        licensed subject to the terms of a separate agreement to be mutually
        agreed upon between the parties at a later date.

28.     ENGINEERING CHANGE NOTICES/PRODUCT CHANGES

        (a)     KOFAX shall give FCPA at least ninety (90) days advance written
                notice of engineering changes that will affect the form, fit or
                function of any Product in FCPA's inventory.

        (b)     KOFAX shall not make any form, fit, or function changes to the
                Product without the approval of FCPA. Subject to KOFAX's Quality
                Procedure, as set forth in the attached Exhibit F, KOFAX will
                document all proposed engineering changes as an Engineering
                Review Order ("ERO"). If applicable, sample of the proposed
                product change shall be provided with each ERO. FCPA shall have
                fifteen (15) business days to accept or reject such engineering
                change.

        (c)     Following FCPA's approval of the ERO, KOFAX shall follow with an
                Engineering Change Order ("ECO") for FCPA's formal acceptance of
                the change. FCPA shall have eight (8) business days from ECO
                delivery for approval. FCPA's failure to approve the ECO within
                this stipulated time, shall deem the ECO officially accepted.

        (d)     Accepted changes will be cut-in with the next production build
                of the Product or Product delivery. If FCPA rejects a change
                which affects the form, fit or


                                 Page 13 of 28
<PAGE>   14

                function, rendering the Product unusable by FCPA, the parties
                shall work together to determine a reasonable resolution to the
                problem. Any safety related ECO's shall be corrected under
                warranty.

        (e)     The implementation of KOFAX's Design and Change Control
                Procedure shall commence with initial production shipments to
                FCPA.

29.     END OF LIFE PRODUCTS

        Should Products be discontinued or should an ECN create modifications to
        the Product that require KOFAX to assign a new Product number to the
        affected Product then FCPA shall be entitled to make an End-of-Life
        ("EOL") buy or return the Product for credit as specified below. Should
        FCPA decide to make an EOL buy the Order must be within thirty (30) days
        of the date of notice and FCPA agrees to take Delivery of that Product
        within thirty (30) days of the date EOL Order is placed.

        FCPA shall use commercially reasonable efforts to sell any Product which
        have been deemed EOL'd during the EOL notice period. Any EOL Products
        remaining unsold and in FCPA's inventory, which was returned to FCPA by
        its OEM's and Distributors upon the date the Product is EOL'd may be
        returned for credit subject to the following terms:

        (a)     All EOL'd Product returns must be made within sixty (60) days
                from the date the Product is EOL'd.

        (b)     FCPA shall receive a credit for all such EOL'd Products
                returned, provided the EOL'd Product being returned was
                purchased and paid for by FCPA within six (6) months of the date
                of EOL notice.

        (c)     Credit shall be based on the then current list price for the
                EOL'd Product as noted on the last version of KOFAX' price list
                containing the EOL'd Product, less any previously given credits
                or returns.

        (d)     FCPA shall return the EOL'd Products utilizing KOFAX's then
                current RMA procedure.

        (e)     Products returned must be new, unused and in factory sealed
                containers.

        (f)     KOFAX shall pay freight charges provided that the choice of
                carrier remains solely with KOFAX.

30.     TERMINATION


                                 Page 14 of 28
<PAGE>   15

        (a)     Either Party may terminate this Agreement in whole or in part
                for any reason and without liability for that termination by
                giving a written ninety (90) day notice of termination to the
                other party.

        (b)     Either party may terminate this Agreement, effective upon
                written notice to the other, if any one of the following events
                occur: (i) the other files a voluntary petition in bankruptcy;
                (ii) the other is adjudicated bankrupt; (iii) the other makes an
                assignment for the benefit of its creditors; (iv) a court
                assumes jurisdiction of the assets of the other under a federal
                bankruptcy or reorganization act; (v) a trustee or receiver is
                appointed by a court for all or a substantial portion of the
                assets of the other; (vi) there is a substantial change in the
                financial conditions of the other; or (vii) the other is unable
                to pay its debts as they become due.

        (c)     Either party may terminate this Agreement upon written notice if
                the other party breaches this Agreement and fails to correct the
                breach within thirty (30) days following the receipt to a
                written notice specifying the breach.

        (d)     Upon termination FCPA's inventory will be repurchased as
                follows: (i) KOFAX shall buy back FCPA inventory of KOFAX
                Products purchased and paid for during the previous six (6)
                months and on hand at FCPA's location as of the effective date
                of termination, and KOFAX shall have the option to buy back FCPA
                inventory of KOFAX Products purchased more than six (6) months
                previously and on hand at FCPA location as of the effective date
                of the termination. All Products returned by FCPA to KOFAX shall
                comply with the following conditions: (1) be returned freight
                prepaid within sixty (60) days of receipt of notification by
                KOFAX, (2) be shipped in the original shipping container to
                eliminate Product damage during shipment, and (3) be received at
                KOFAX's facility new, unused, undamaged and in good working
                condition.

        (e)     Upon the giving by KOFAX or FCPA of notice of election to
                terminate this Agreement, excluding termination as provided in
                subsection (b) above, KOFAX agrees to accept Orders on cash
                terms, or such other terms as may be mutually agreed, for
                Products which FCPA is contractually obligated to furnish prior
                to termination and does not have in its inventory, provided that
                FCPA within ten (10) days after the expiration of this Agreement
                or termination, as hereinabove provided, furnishes evidence to
                KOFAX's satisfaction of the existence of the contractual
                obligation; and provided further that KOFAX has a sufficient
                number of Products in stock and available for distribution to
                supply the same to FCPA.

        (f)     BOTH PARTIES ACKNOWLEDGE THAT IN THE EVENT OF TERMINATION OF
                THIS AGREEMENT NEITHER PARTY SHALL HAVE ANY RIGHT TO DAMAGES OR
                INDEMNIFICATION OF ANY NATURE, WHETHER BY WAY OF LOSS OF
                GOODWILL, FUTURE PROFITS, OR REVENUE, ON ACCOUNT OF
                EXPENDITURES, INVESTMENTS,


                                 Page 15 of 28
<PAGE>   16

        LEASES, OR OTHER COMMITMENTS IN CONNECTION WITH THE BUSINESS OR GOODWILL
        OF EITHER PARTY, OR OTHERWISE

31.     MARKET DEVELOPMENT

        (a)     KOFAX agrees to cooperatively work with FCPA in developing joint
                marketing programs for KOFAX VRS Ready scanners. KOFAX will
                offer cooperative marketing funds as well as supplement joint
                efforts with its own marketing programs.

        (b)     KOFAX will terminate current plans to market a KOFAX VRS
                configuration for Fujitsu M-Series video scanners through the
                FCPA channel and will allow FCPA to OEM several VRS components
                for inclusion in new FCPA VRS Ready scanners.

        (c)     KOFAX will not allow the shipment of non Fujitsu VRS enabled
                scanners prior to the first customer ship date of the KOFAX VRS
                Ready M3097DE scanner. For purposes of this Section, first
                customer ship shall be defined to mean no sooner than twenty
                (20), but no more than sixty (60), days KOFAX delivery of the
                initial purchase order issued by FCPA ("FCS").

        (d)     KOFAX agrees to not allow the inclusion of the VRS Auto
                Adjustment brightness and contrast features in non-Fujitsu VRS
                scanners prior to six (6) months after the first shipment by
                FCPA of a mutually agreed upon version 1.03 of the Product.

        (e)     FCPA will include a VRS logo, as approved by KOFAX, which will
                be installed by FCPA in a prominent location on the front of
                each scanner.

        (f)     FCPA agrees to create an additional part number consisting of
                the three VRS components (VRS Grayscale Scanner Adapter, VRS
                cable, VRS software) which can be sold by FCPA for use with
                existing M-Series video scanners in the field as an upgrade kit.

        (g)     FCPA agrees to use commercially reasonable efforts to
                participate in cooperative marketing efforts in conjunction with
                KOFAX's VRS marketing efforts.

        (h)     A Shockwave version of the VRS interactive demo CD presentation
                will be provided to FCPA for use on the FCPA website.

32.     PUBLICITY

        Both parties agree not to disclose the terms and conditions of this
        Agreement, except as may be required by law or government regulation,
        including, without limitation, federal securities laws, and except to a
        party's accountants and attorneys without the prior written consent of
        the other party. The foregoing notwithstanding, either party may
        disclose that an Agreement has been signed by the parties for supply of
        Products by KOFAX to FCPA on an OEM basis.


                                 Page 16 of 28
<PAGE>   17

33.     FORCE MAJEURE

        Neither FCPA nor KOFAX shall be liable to the other for delays in the
        performance of this Agreement if such delay is caused by strike, riots,
        wars, government regulations, acts of God, fire, flood, or other causes
        beyond its control; provided, however, if any such delay by KOFAX
        continues thirty (30) days or more, then FCPA shall have the option,
        exercisable by written notice to cancel all or any portion of Orders
        placed hereunder and to cancel this Agreement without charge or
        liability.

34.     GOVERNING LAW

        This Agreement shall be governed by and interpreted in accordance with
        the laws of the State of California.

35.     NOTICES

        Written notices are to be sent to FCPA at

                Fujitsu Computer Products of America, Inc.
                2904 Orchard Parkway
                San Jose, CA 95134
                Attn:   Manager, Contracts Administration

Written notices are to be sent to the KOFAX at:

                3 Jenner
                Irvine, CA 92618
                Attn:   Manager, Contracts Administration

36.     ASSIGNMENT

        Neither this Agreement nor any of the rights and obligations arising
        from it may be assigned or transferred in whole or in part to any third
        party without the prior written consent of the other party and any
        attempted assignment in violation of this Section shall be void.
        Notwithstanding the aforementioned, FCPA may assign this Agreement to
        its subsidiary or parent companies without prior notice to KOFAX and
        either party may assign this Agreement in connection with the sale of
        the business to which this Agreement relates. However, FCPA shall
        provide notice of such assignment to KOFAX within thirty (30) days after
        assignment.

37.     RELATIONSHIP

        This Agreement does not make either party the employee, agent, joint
        venture, partner or legal representative of the other for any purpose
        whatsoever. In fulfilling its obligations under this Agreement, each
        party shall be deemed to be an independent contractor.


                                 Page 17 of 28

<PAGE>   18

38.     WAIVER

        No failure by either party to assert any right hereunder shall be deemed
        to be a waiver of such right in the event of the continuation or
        repetition of the circumstances giving rise to such right. The exercise
        of any right or remedy by either party shall not be deemed a waiver of
        any other right or remedy granted under this Agreement or available at
        law.

39.     AMENDMENT

        This Agreement may not be amended, except by written agreement signed by
        both parties. 

40.     SURVIVAL

        (a)     Even when this Agreement is terminated, cancelled or expires,
                any individual contract according to this Agreement of which the
                fulfillment date is beyond the termination, cancellation or
                expiration date shall survive this Agreement until the date of
                its final fulfillment.

        (b)     The rights and obligations of the parties hereto accrued at the
                time of termination, cancellation or expiration of this
                Agreement and under Sections 12, 14, 15, 18, 20, 23, 24, 25, 26,
                27, 30, 34, 41, 42 and 43 shall survive any termination,
                cancellation or expiration of this Agreement.

41.     RIGHTS UPON TERMINATION OF AGREEMENT

        The parties recognize that termination of this Agreement in accordance
        with its terms or its failure to be renewed or extended may result in
        loss or damage to either party but hereby expressly agree that neither
        party shall be liable to the other by reason of any loss of damage
        resulting from such termination of this Agreement by the other or the
        failure of the Agreement to be renewed or extended (including, without
        limitation, any loss of prospective profits or any damage occasioned by
        loss of goodwill) or by reason of any expenditures, investments, leases
        or commitments made in anticipation of the continuance of this
        Agreement. The foregoing, however, shall not in any way relieve either
        party from liability to the other for damages arising out of any
        violation or breach of this Agreement.

42.     LIMITATION OF LIABILITY

        EXCEPT AS STATED HEREIN, KOFAX DISCLAIMS ALL OTHER WARRANTIES, EXPRESS
        OR IMPLIED, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND
        FITNESS FOR A PARTICULAR PURPOSE. KOFAX SHALL NOT BE LIABLE FOR
        INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM ANY USE,
        LEASE OR SALE OF THE PRODUCTS BY FCPA.

        EXCEPT AS EXPRESSLY PROVIDED HEREIN, IN NO EVENT SHALL EITHER PARTY BE
        LIABLE FOR INDIRECT, INCIDENTAL, PUNITIVE, SPECIAL OR


                                 Page 18 of 28
<PAGE>   19

        CONSEQUENTIAL DAMAGES ARISING IN CONNECTION WITH THIS AGREEMENT, ITS
        NEGOTIATION, FORMATION, BREACH, EXPIRATION OR TERMINATION.

43.     DISPUTE RESOLUTION

        Any controversy arising out of or relating to this Agreement, any
        modifications or extension hereof, or any Order, sale or performance
        hereunder, including any claim for damages or rescission, or both, shall
        be settled, by three arbitrators in Santa Clara County, California, if
        instituted by KOFAX, or Orange County, California if initiated by FCPA
        in accordance with the Commercial Rules then obtaining of the American
        Arbitration Association. Judgment on the award may be entered in any
        Court of competent jurisdiction. The parties consent that any process or
        notice of motion or other application to either of said courts, and any
        paper in connection with arbitration, may be served by certified mail,
        return receipt requested, or by personal service or in such other manner
        as may be permissible under the rules of the applicable court or
        arbitration tribunal, provided a reasonable time for appearance is
        allowed. The parties further agree that arbitration proceedings must be
        instituted within eighteen (18) months after the claimed breach
        occurred, and that the failure to institute arbitration proceedings
        within such period shall constitute an absolute bar to the institution
        of any proceedings and a waiver of all such claims. The prevailing party
        in any arbitration or other legal proceedings shall be entitled, in
        addition to any other rights or remedies it may have, to reimbursement
        for its expenses incurred thereby and in any subsequent enforcement of a
        judgment including court and arbitration costs, reasonable attorneys'
        fees, arbitrator's fees, and witness fees including those of expert
        witnesses.

44.     ENTIRE AGREEMENT

        This Agreement, including the attachments, constitutes the entire
        agreement of the parties with respect to the subject matter hereof, and
        supersedes all previous agreements by and between the parties, as well
        as all proposals, oral or written, and all negotiations, conversation,
        and understandings heretofore had between the parties related to the
        subject matter of the Agreement. This Agreement supersedes any terms and
        conditions stated in any Order, acceptance or confirmation of Order to
        the extent they are inconsistent with this Agreement or purport to
        create obligations or rights additional to those set forth in this
        Agreement.

45.     HEADING

        Headings used in this Agreement are for convenience only and shall not
        be used in interpreting the provisions of this Agreement.


                                 Page 19 of 28

<PAGE>   20

IN WITNESS WHEREOF, this Agreement has been executed by duly authorized
representatives of both parties hereto as of the date first written above.

KOFAX IMAGE PRODUCTS, INC.            FUJITSU COMPUTER PRODUCTS OF AMERICA, INC.

Signature:  /s/ RICHARD M. MURPHY     Signature:  /s/ K. T. PARKER
          ------------------------              -----------------------------
Name:  Richard M. Murphy              Name:  KEVIN T. PARKER
     -----------------------------         ----------------------------------

Title:  V.P. SALES                    Title:  V.P. FINANCE AND ADMINISTRATION
      --------------------------            ---------------------------------

Date:  2/5/99                         Date:  2/1/99
     -----------------------------         -----------------------------------


                                 Page 20 of 28

<PAGE>   1

                                                                   EXHIBIT 11.1
             
                  COMPUTATION OF DILUTED NET INCOME PER SHARE

<TABLE>
<CAPTION>
                                                                   THREE MONTHS ENDED              NINE MONTHS ENDED 
                                                                     MARCH 31, 1999                 MARCH 31, 1999
                                                                 ----------------------         ------------------------
<S>                                                              <C>       <C>                  <C>             <C>
CALCULATION OF DILUTED NET INCOME PER SHARE AT MARCH 31, 1999

Weighted average common shares                                                5,306,042                        5,282,278
Common stock options outstanding using the treasury stock method                167,794                          130,127
                                                                             ----------                       ----------
Total diluted weighted average common shares outstanding                      5,473,836                        5,412,405
Net income                                                                   $1,258,994                       $3,347,286
Diluted net income per share                                                       0.23                             0.62
                                                                             ==========                       ==========

Weighted Common Stock Options                                       477,187                        413,723
Weighted average outstanding exercise price                      $     5.56                     $     5.06
                                                                 ----------                     ----------
Gross proceeds                                                    2,651,442                      2,092,404
Repurchase price                                                 $     8.57                     $     7.38
                                                                 ----------                     ----------
Shares repurchased                                                  309,393                        283,596
                                                                 ----------                     ----------
Net shares                                                          167,794                        130,127
                                                                 ==========                     ==========
</TABLE>

<TABLE>
<CAPTION>

                                                                   THREE MONTHS ENDED              NINE MONTHS ENDED 
                                                                     MARCH 31, 1998                  MARCH 31, 1998
                                                                 ----------------------         -----------------------
<S>                                                              <C>         <C>                <C>          <C>
CALCULATION OF  DILUTED NET INCOME PER SHARE AT MARCH 31, 1998

Weighted average common shares                                                5,367,122                       3,829,589
Conversion of Preferred Stock to Common Stock                                                                   992,826
Common stock options outstanding using the treasury stock method                118,804                         134,874
                                                                             ----------                      ----------
Total diluted weighted average common shares outstanding                      5,485,926                       4,957,289
Net income                                                                   $  834,180                      $2,251,381
Diluted net income per share                                                       0.15                            0.45
                                                                             ==========                      ==========

Weighted Common Stock Options                                       355,825                        355,825 
Weighted average outstanding exercise price                      $     4.03                     $     4.03 
                                                                 ----------                     ---------- 
Gross proceeds                                                    1,433,975                      1,433,975 
Repurchase price                                                 $     6.05                     $     6.49 
                                                                 ----------                     ---------- 
Shares repurchased                                                  237,021                        220,951 
                                                                 ----------                     ---------- 
Net shares                                                          118,804                        134,874 
                                                                 ==========                     ========== 

</TABLE>




<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                          19,851
<SECURITIES>                                     5,467
<RECEIVABLES>                                    5,670
<ALLOWANCES>                                       564
<INVENTORY>                                      1,769
<CURRENT-ASSETS>                                33,712
<PP&E>                                           6,342
<DEPRECIATION>                                   4,857
<TOTAL-ASSETS>                                  36,644
<CURRENT-LIABILITIES>                            6,003
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        16,601
<OTHER-SE>                                      14,040
<TOTAL-LIABILITY-AND-EQUITY>                    36,644
<SALES>                                              0
<TOTAL-REVENUES>                                28,091
<CGS>                                                0
<TOTAL-COSTS>                                    6,384
<OTHER-EXPENSES>                                17,348
<LOSS-PROVISION>                                    95
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  5,168
<INCOME-TAX>                                     1,821
<INCOME-CONTINUING>                              3,347
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,347
<EPS-PRIMARY>                                     0.63
<EPS-DILUTED>                                     0.62
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission